OP
AZN icon

ORG Partners’s AstraZeneca AZN Stock Holding History

ORG Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$61.9K Hold
337
– – 0.01% 542
2025
Q3 		$51.7K Buy
337
+2
+0.6% +$303 0.01% 575
2025
Q2 		$47.8K Hold
335
– – 0.01% 554
2025
Q1 		$48.6K Buy
335
+5
+2% +$723 0.01% 488
2024
Q4 		$43.3K Sell
330
-280
-46% -$39.2K 0.01% 589
2024
Q3 		$95.1K Buy
610
+126
+26% +$20.3K 0.02% 394
2024
Q2 		$75.5K Hold
484
– – 0.01% 691
2024
Q1 		$65.2K Buy
+484
New +$64.1K 0.12% 113
2023
Q4 		– Sell
-22
Closed -$2.91K – 1142
2023
Q3 		$2.91K Sell
22
-181
-89% -$24.7K ﹤0.01% 1025
2023
Q2 		$27.2K Buy
+203
New +$29.9K ﹤0.01% 806

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ORG Partners's AZN Position: Q4 2025 in Review

ORG Partners held its AstraZeneca (AZN) position steady in Q4 2025 at 337 shares worth $61.9K. The position accounts for 0.01% of the portfolio, ranked #542.

ORG Partners first reported a position in AZN in Q2 2023 and has held it in 10 quarters since. The position peaked at $95.1K in Q3 2024. 1,405 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

  • ORG Partners held 337 shares of AstraZeneca worth $61.9K as of Q4 2025.
  • ORG Partners left its AstraZeneca share count unchanged in Q4 2025.
  • AstraZeneca made up 0.01% of ORG Partners's portfolio in Q4 2025, its #542 holding.
  • ORG Partners first reported a position in AstraZeneca in Q2 2023 and has held it in 10 quarters since.
  • ORG Partners's AstraZeneca position peaked at $95.1K in Q3 2024.
  • 1,405 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.